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Research collaborations occur more frequently today than 
they did in the past due to a growing likelihood of research 
funding for interdisciplinary projects, the need to externally 
validate your finding or to do multicentric studies and 
advances in communication technologies. It is extraordinarily 
rare to find a publication in almost any discipline in which 
there is a single author. Collaborations take place in a variety 
of forms, including the borrowing and lending of data, 
resources and equipment between researchers; seeking input 
from an expert in a different discipline; and partnering with 
colleagues who have a similar background or field of 
knowledge for fresh ideas and abilities. A mistake frequently 
made by Ph.D. students—is to e-mail a scientist telling them 
you want to do research just like theirs, then ask for data. 
Conferences are great settings in which to initiate 
collaborations because of the many opportunities they 
provide for one-on-one scientific discussion. But often, in 
particular for young scientist, the first step is the hardest. 
One low-risk way to try a new collaboration is to offer to 
analyze your collaborator’s published data in a new way, or 
to work on a pilot study, before putting a grant proposal 
together and committing yourself to the relationship, 
It is essential for collaborating researchers to establish a 
clear management plan or more simply a material transfer 
Agreement at the beginning of the endeavor in order to avoid 
the potential difficulties which they might otherwise 
encounter. This plan should include the goals and direction of 
the study, responsibilities of each contributor, research 
credit and ownership details, and publication authorship. 
Team members must be open with one another, keeping 
colleagues informed of developments, changes and problems. 
Think hard and carefully about how to exclude opportunities 
for research misconduct. While you need to have a certain 
level of trust, you also need to have a procedure in place to 
verify every collaborator's data. If somebody feels offended 
by the idea of having their data verified, then you probably 
don’t want to work with that person. One potential risk is to 
overestimate what you can accomplish. This can be 
problematic since your collaborators’ work will be dependent 
on yours. Reliability is a great asset for collaboration.  
A good collaborator learns to be realistic about what he or 
she can deliver. As with any relationship, collaboration 
means sharing both the good and the bad. With the correct 
procedures—and the right collaborators—in place, 
collaborations should be both effective and enjoyable.  
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Adjuvant breast radiotherapy (B-RT) remains an essential 
aspect of breast conserving therapy.  Given the increased 
uptake and improvement in screening, improved personalized 
treatment decisions with modern systemic management, and 
increased utilization of B-RT in women with DCIS there are 
increasing numbers of survivors with life expectancies 
measured in decades.   As a result there is increasing interest 
in minimizing both acute and late RT toxicity.  In the era of 
rapid and innovative technological advances, one simple 
intervention that shows promise to improve the quality of life 
(QoL) in women receiving B-RT is positioning of the breast. 
 In the acute setting women, especially those with large 
pendulous breasts, can experience significant skin toxicity 
including moist desquamation which has been correlated to 
long term toxicity and decreased QoL.  B-RT in the prone 
position has been shown to decrease dose to the lung and 
heart in the majority of patients, while also improving dose 
homogeneity which may result in less acute skin toxicity.  For 
example, a retrospective review of acute toxicity in women 
with large pendulous breasts treated in the prone position at 
our centre showed that 9/62 (14.5%) experienced moist 
desquamation, which is significantly lower than the expected 
40-60% rate observed in the literature for large breasted 
women   In 12 of these patients that underwent simulation in 
both the prone and supine position, plans went on to be 
independently optimized using standardized planning. Plans 
generated in the prone position were consistently more 
homogenous than seen for the corresponding supine plan.  
Potential tradeoffs of prone B-RT include less incidental 
coverage of the chest wall and axillary lymph nodes as 
compared to treatment in the supine position, as well as 
currently being limited to patients being treated to the 
breast alone. 
 To minimize long term cardiac events, breath hold 
techniques including those using active breathing control 
(ABC) have been shown to decrease heart exposure.  
Unfortunately this technique/technology is not universally 
available, and some patients are unable to tolerate the 
process.  A potential alternate is positioning patients in 
either the isocentric lateral decubitus or reverse semi-
decubitus (RSD) position, where breast tissue is displaced 
from the chest wall resulting in less exposure to the lung and 
heart.  We completed a retrospective planning study on 12 
women with left sided breast cancer with unfavorable 
cardiac anatomy simulated using supine, RSD and ABC 
techniques.  The mean heart dose and mean LAD dose was 
higher in the supine position (9.6 and 3.8Gy) than either the 
RSD (5.7 and 2.8Gy) or ABC (3.2 and 1.7Gy) positions (p= 
0.004 to 0.005).  Although reduction in heart exposure was 
most pronounced using the ABC technique, the RSD technique 
could be a suitable alternative in women unable to perform 
ABC. Trade-offs of the RSD technique include less reliable 
immobilization and decreased patient comfort, thus creating 
the potential for suboptimal reproducibility.  
 Our work and that of others regarding breast positioning to 
decrease acute and late radiation induced toxicity which will 
be reviewed in this presentation has lead to our multicentre 
randomized controlled trial comparing adjuvant breast 
radiation in the prone vs supine position in women with large 
pendulous breasts, and a proposed study prospectively 
comparing RSD to ABC in women with left sided disease. 
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The presentation will begin with a discussion of the rationale 
for the use of respiratory control techniques in breast cancer. 
Data pertaining to the dosimetric gains of breath-hold and 
gating techniques will be reviewed and the expected clinical 
gains will be modelled based on the Darby data (NEJM, 2013). 
The range of respiratory control options will be presented 
and the pros and cons of each technique discussed.  The UK 
HeartSpare Study will be reviewed as an example of how to 
use research to increase national use of heart-sparing breast 
radiotherapy techniques. The presentation will finish with a 
discussion of potential future applications of respiratory 
control techniques and how to integrate them with advanced 
radiotherapeutic approaches. 
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The use of IMRT for many cancers has increased in recent 
years.  In general, IMRT has been shown to improve 
conformality of target volume coverage, with improved high 
dose sparing of organs at risk (OAR), however, at the cost of 
increased volumes of normal tissue receiving lower doses of 
radiation.  Improved treatment planning and delivery 
technology have greatly advanced the practice of IMRT over 
time. 
Among women with breast cancer, two distinct “types” of 
IMRT are used, in very different circumstances with fairly 
well-defined benefits and costs.  Tangential or field in field 
IMRT has been used to improve delivery of chest wall/breast 
radiotherapy.  Inverse planned multifield or arc IMRT has 
been used to improve delivery of chest wall/breast + nodal 
radiotherapy. 
Tangential or field in field IMRT, either inverse or forward 
planned, has been shown to increase the ability of 
radiotherapy departments to improve the quality of 
treatment planning and delivery of tangential breast 
radiotherapy, through more efficient planning processes, 
improved dose homogeneity in the breast, and increased 
automation, while possibly decreasing toxicity.  
Inverse planned multifield or arc IMRT has been shown to 
improve dose conformality, particularly to facilitate inclusion 
of more complex treatment volumes, e.g. chest wall + 
internal mammary nodes,  in the anatomic setting of 
significant OAR, such as the heart and lungs.  Literature 
suggests that this is typically at the cost of higher volumes of 
normal tissue receiving low doses, greater dose 
inhomogeneity, and greater resources required for treatment 
planning and delivery.   
This session will discuss the balance between the benefits 
and downsides of the use of both types of IMRT, review 
potential indications for both, and provide illustrative 
examples of clinical cases and treatment plans. 
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Radiotherapy has a long history of examining the risks and 
documenting adverse events. Pro-active risk assessment and 
the reactive analyses of events should be used in parallel in 
order to provide optimal results for risks management. 
Different methods of risks assessment are available but a 
combination of methods is needed to perform a complete 
evaluation. The reactive (retrospective) analysis of events is 
directly related to the recording and the reporting of events. 
Detailed analyses should be reported through the local 
and/or external reporting system with the primarily purpose 
of more widely disseminating the experience learnt to other 
professionals. It is important to document all funding and 
corrective actions in order to prevent the re-occurrence of 
such events and especially, to share the experience learnt as 
a result of the event. Two levels of recommendations should 
be provided: recommendations to institutions that provide 
radiotherapy services whose primary responsibility is patient 
safety and secondly, to national authorities which focus on 
the needs for strong support at the national or original level 
to promote culture that value risks management and safety. 
In the area of new technologies, educational program and 
practice risk analyses should be favored for the development 
or update the national strategy on quality and risk 
management to promote a safety culture in radiotherapy. 
Clinical audits and regulator inspections are also considered 
to play many important roles in a national strategy. These 
actions are aiming to identify assessing and analyzing and 
understanding on risk issues in order to rich an optimal 
balance of risks benefits and costs. All the actors involved in 
radiotherapy process should be concerned by these 
approaches (physicians, physicists, nurses, radiation 
technologists and companies). The most relevant advice that 
might be recommended to radiation oncologists aiming to 
implement new technologies is to participate to trials 
including a relevant quality assurance program.  
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The professional radiotherapy (RT) team comprised of 
radiation oncologists, medical physicist and radiation 
therapist (RTT) work through an integrated process to plan 
and deliver RT to cancer patients. Each step requires quality 
control (QC) and quality assurance (QA) measures to prevent 
errors and to give high confidence that patients will receive 
the prescribed treatment correctly. Not unlike the other 
professionals, the RTT is involved in a number of QC and QA 
measures. However, RTTs often are the last security barrier 
that will prevent a near incident from becoming an incident 
as they are often the pivot point between the pre-treatment 
phase and the treatment phase of the RT process.  
With the recent advances in RT, including intensity-
modulated and image-guided RT, QA demands on RTTs have 
dramatically increased. While the individualisation of 
treatments, precise positioning verification processes and 
increased in IT complexity have optimized patient treatment 
parameters, they also have resulted in the need for 
